Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Eyelid Sebaceous Gland Carcinoma × Sentinel Lymph Node Biopsy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Mouth Neoplasms 1 Lymphedema 1 HIV Infections 1 Fallopian Tube Neoplasms 1 Eyelid Sebaceous Gland Carcinoma 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Anus Neoplasms 1

Interventions

Technetium Tc 99m Sulfur Colloid 1 Sentinel Lymph Node Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00832429 2025-07-04

Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid

M.D. Anderson Cancer Center

Phase 2 Completed

20 enrolled 6 charts

Eyelid Sebaceous Gland Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡